Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-blind, Randomized, Parallel-group, Vehicle-Controlled Study to Evaluate the Safety and Clinical Equivalence of a Generic Azelaic Acid Gel, 15% and the Reference Listed Finacea® (Azelaic Acid) Gel, 15% in Patients With Moderate Facial Rosacea.
Conditions
Interventions
Azelaic acid
Vehicle
+1 more
Locations
30
United States
Site 24
Fremont, California, United States
Site 22
Santa Monica, California, United States
Site 1
Brandon, Florida, United States
Site 3
Fort Myers, Florida, United States
Site 27
Jacksonville, Florida, United States
Site 19
Miami, Florida, United States
Start Date
July 1, 2013
Primary Completion Date
September 1, 2014
Completion Date
September 1, 2014
Last Updated
June 2, 2020
NCT04214483
NCT06969300
NCT06873087
NCT06271135
NCT04336163
NCT05771298
Lead Sponsor
Actavis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions